Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era.
about
Burden of pneumonia and meningitis caused by Streptococcus pneumoniae in China among children under 5 years of age: a systematic literature reviewPneumococcal conjugate vaccine in HIV-infected and HIV-exposed, uninfected children.Decreased Streptococcus pneumoniae susceptibility to oral antibiotics among children in rural Vietnam: a community studyCost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese ChildrenSerotypes and Clonal Diversity of Streptococcus pneumoniae Causing Invasive Disease in the Era of PCV13 in Catalonia, SpainNanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae.Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine.Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines?Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.Use of the 13-valent pneumococcal conjugate vaccine in infants and young children.Prevention of acute otitis media using currently available vaccines.Pneumococcal conjugated vaccine: PHiD-CV.Current status of pneumococcal vaccines: lessons to be learned and new insights.27th Annual Meeting of the European Society for Pediatric Infectious Disease.Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine.6th World Congress of the World Society for Pediatric Infectious Diseases (WSPID)Estimating the cost-effectiveness of an infant 13-valent pneumococcal conjugate vaccine national immunization program in China
P2860
Q28742681-544CD084-4523-48B5-9008-704ADA4D2EE5Q30235055-88455995-6A85-45AA-812E-A76C024041B7Q30980181-845CE436-20E9-4EA2-AA82-97CAC73445D3Q35186834-5667F6A4-062A-4314-96F8-F61DF7F5C6D9Q35949066-8ECC8B74-2F00-4C58-BFDB-31DB33A8F0D9Q36826926-E3EFC26E-AAB0-4EB2-9322-A7893FCF5F3AQ37559623-92D830DC-7365-4E22-8D3F-8874A3B35BC9Q37631055-89510B3D-A767-4CE2-90B6-2C880536CC98Q37857254-2F831F9F-1D45-4574-B1EC-536F58476E8AQ37991405-8CFA16DB-A4E9-4014-ABE8-0BB36DE893B7Q37996088-C806F4A2-E729-4850-90E5-346AEE6594A6Q42638322-F846CD2B-5483-4240-A1D1-87B182A01BEAQ43765485-D269C2DF-DE9D-4FAE-A594-DA57B0769F94Q43777687-0E54A50D-649A-4D27-90F2-B7B9A7ECFCC7Q47429883-C94B2CE8-23CA-4A42-BC35-168729DF8D26Q57108439-291B7029-9C62-417B-8B35-DCE4AF5CA9C2Q57930051-1917BE48-7A20-410C-9D6E-9E237959503B
P2860
Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Pneumococcal conjugated vaccin ...... ements in the postvaccine era.
@en
Pneumococcal conjugated vaccin ...... ements in the postvaccine era.
@nl
type
label
Pneumococcal conjugated vaccin ...... ements in the postvaccine era.
@en
Pneumococcal conjugated vaccin ...... ements in the postvaccine era.
@nl
prefLabel
Pneumococcal conjugated vaccin ...... ements in the postvaccine era.
@en
Pneumococcal conjugated vaccin ...... ements in the postvaccine era.
@nl
P2860
P1476
Pneumococcal conjugated vaccin ...... ements in the postvaccine era.
@en
P2093
Ener Cagri Dinleyici
Zeynel Abidin Yargic
P2860
P304
P356
10.1586/14760584.7.9.1367
P577
2008-11-01T00:00:00Z